Overview
This article presents AVMCH's structured perspective on immunothperapy advances in head and neck cancers: 2025 update, consolidating current evidence, practical protocols, and implementation insights for academic and clinical teams.
Conclusion
The findings reinforce AVMCH's commitment to evidence-based medical practice and continuous quality advancement in patient care and education.